Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-011 · synthetic case ANEM-FX-07
Pancytopenia
Hb 8.5, WBC 2.4, platelets 62.
Purpose: Hb 8.5, WBC 2.4, platelets 62.
Inputs the engine received
CBC and reticulocytes
- Hemoglobin
- 8.5 g/dL
- MCV
- 104 fL
- WBC
- 2.4 ×10³/µL
- Platelets
- 62 ×10³/µL
Patient
- Age
- 72 years
- Sex
- Male
What the engine reports
This pattern raises marrow failure, infiltration or severe megaloblastic anemia, and needs hematology evaluation.
Detected clinical pattern
Cytopenias Raising Marrow Involvement
Moderate anemia, macrocytic. A pattern for physician review; the cause still has to be found.
- Severity: Moderate anemia (Hb 8.5 g/dL)
- Morphology: Macrocytic (MCV >100)
Recommended next steps
For physician consideration. Urgent review always comes first.
- 1Hematology evaluation of the cytopenias.
Differentials, pitfalls and contradicting signals
- Non-vitamin causes of macrocytosis present: age ≥60 with cytopenias. They can coexist with a vitamin deficiency.
Missing information
- Reticulocyte percentage with hematocrit (marrow response).
- Ferritin (and transferrin saturation).
- Vitamin B12 and folate (macrocytic anemia).
Evidence and rule trace · 5 rules
AN-17Cytopenias: marrow involvement possible
Inputs: Hb 8.5, WBC 2.4, platelets 62
Pattern that raises marrow failure or infiltration.
AN-18Macrocytosis from non-vitamin causes
Inputs: age ≥60 with cytopenias
Non-vitamin causes of macrocytosis are present.
AN-MISS-01Information needed
Inputs: Reticulocyte percentage with hematocrit · Ferritin · Vitamin B12 and folate
First-line studies are incomplete.
Evidence
- EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
- EV-TEFFERI-2003 · Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003;78(10):1274-1280.
- EV-DEVALIA-2014 · Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513.
Physician adjudication required. Clinical decision support for physician review. This output classifies anemia by morphology and marrow response and lists patterns and safety considerations. It does not diagnose a cause, rank causes by probability, or select treatment or transfusion. Physician adjudication is required.
Change the values
The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.
Morphology
✓ Microcytic
MCV <80 fL
✓ Normocytic
MCV 80–100 fL
● Macrocytic
MCV >100 fL
Marrow response (reticulocyte production index)
○ Inadequate · RPI <2
Hypoproliferative: deficiency, inflammation, kidney, marrow
○ Appropriate · RPI ≥2
Blood loss, hemolysis or recovery
No stage is assigned for the values entered.
CBC and reticulocytes
- <7
- 7–8
- 8–11
- 11–13
- ≥13
Patient
Iron, vitamins and inflammation
Hemolysis, kidney and thyroid
250 U/L is assumed when empty.
Blood film and other context
More anemia cases
ANEM-FX-01
Microcytic anemia with low ferritin
A 36-year-old, Hb 9.9, MCV 72, ferritin 6, TSAT 7%.
ANEM-FX-02
Microcytic anemia, normal iron indices and a low Mentzer index
MCV 62, RBC 5.7.
ANEM-FX-03
Macrocytic anemia with low B12 and hypersegmented neutrophils
MCV 112.
ANEM-FX-04
Hemolysis: reticulocytes 12%, LDH 640, haptoglobin 5
Spherocytes and a positive DAT.
ANEM-FX-05
Anemia in CKD
eGFR 28, normocytic, low reticulocytes, iron replete.
ANEM-FX-06
Anemia of inflammation
CRP 30, ferritin 340, TSAT 12%.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.
